CytomX Therapeutics, Inc. announced that on December 16, 2019, the Company granted six new employees options to purchase a total of 36,800 shares of the Company’s common stock at an exercise price per share equal to $7.26, which was the closing trading price on December 16, 2019, the date of the grant.
December 17, 2019
· 2 min read